ARCL Organics

When is the next results date for ARCL Organics?

No Upcoming Board Meetings

Has ARCL Organics declared dividend?

No Dividend History Available

Is ARCL Organics overvalued or undervalued?

As of July 18, 2024, ARCL Organics is fairly valued with a PE ratio of 16.53 and an EV to EBITDA of 9.24, but despite a strong 1Y return of 361.31%, it does not qualify as a compelling investment compared to peers.

As of 18 July 2024, the valuation grade for ARCL Organics has moved from risky to does not qualify, indicating a significant change in its investment profile. The company appears to be fairly valued, with a PE ratio of 16.53, an EV to EBITDA of 9.24, and a ROCE of 19.92%. In comparison to peers, Chambal Fertilisers & Chemicals Ltd. has a more attractive PE ratio of 13.11, while Coromandel International Ltd. is deemed very expensive with a PE of 37.58.<BR><BR>Despite the recent stock performance showing a 1Y return of 361.31% compared to the Sensex's 7.53%, the current valuation metrics suggest that ARCL Organics is not undervalued. The company's ratios indicate it is positioned reasonably within its sector, but it does not present a compelling case for investment at this time.

What is the technical trend for ARCL Organics?

As of June 2, 2025, ARCL Organics shows a mildly bullish trend, supported by a bullish MACD and daily moving averages, but tempered by a mildly bearish KST and Dow Theory signals.

As of 2 June 2025, the technical trend for ARCL Organics has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the daily moving averages are also bullish, indicating some positive momentum. However, the weekly KST is mildly bearish and Dow Theory suggests a mildly bearish stance on the weekly timeframe. The Bollinger Bands on the monthly chart are mildly bullish, which provides some support to the overall mildly bullish outlook. The RSI shows no signals on both weekly and monthly timeframes, indicating a lack of momentum confirmation. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and daily moving averages, tempered by the mildly bearish KST and Dow Theory signals.

Who are the peers of the ARCL Organics?

ARCL Organics' peers include Alufluoride, Kesar Petroprod., Hind. Organ. Chem., Sadhana Nitro, Oriental Carbon, IVP, Kanchi Karpooram, ZRZ Bioenergy, and Polychem. Notably, ARCL Organics has a 1-year return of 258.88%, significantly higher than its peers, with Kesar Petroprod. leading at 59.06% and Sadhana Nitro trailing at -88.23%.

Peers: The peers of ARCL Organics are Alufluoride, Kesar Petroprod., Hind.Organ.Chem., Sadhana Nitro, Oriental Carbon, IVP, Kanchi Karpooram, ZRZ Bioenergy, and Polychem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride, while Average management risk is found at Kesar Petroprod., Sadhana Nitro, Oriental Carbon, IVP, Kanchi Karpooram, and Polychem, and the rest. Below Average management risk is present at Hind.Organ.Chem., ZRZ Bioenergy, and Archit Organosys. Growth is Excellent at Alufluoride, Good at Kesar Petroprod. and IVP, Average at Sadhana Nitro, Oriental Carbon, Kanchi Karpooram, and Polychem, and Below Average at Hind.Organ.Chem., ZRZ Bioenergy, and Archit Organosys. Capital Structure is Excellent at Oriental Carbon and Kanchi Karpooram, Good at Alufluoride and ARCL Organics, Average at Archit Organosys, and Below Average at Kesar Petroprod., Hind.Organ.Chem., Sadhana Nitro, IVP, ZRZ Bioenergy, and Polychem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kesar Petroprod. at 59.06%, while the peer with the lowest is Sadhana Nitro at -88.23%. ARCL Organics has a significantly higher 1-year return of 258.88%. Additionally, the six-month return is negative for Sadhana Nitro, Hind.Organ.Chem., IVP, and Polychem.

Who are in the management team of ARCL Organics?

As of March 2016, the management team of ARCL Organics includes Trinetra Gokarannath Bajpai (Director), Suraj Ratan Mundhra (Chairman), Mukesh Mundhra (Director), Mihir Kumar Ghosh (Director), and Ajay Kumar Minani (Whole-time Director). These individuals are responsible for the company's governance and operations.

As of March 2016, the management team of ARCL Organics includes the following individuals:<BR><BR>1. Trinetra Gokarannath Bajpai - Director<BR>2. Suraj Ratan Mundhra - Chairman<BR>3. Mukesh Mundhra - Director<BR>4. Mihir Kumar Ghosh - Director<BR>5. Ajay Kumar Minani - Whole-time Director<BR><BR>These members play key roles in the governance and operational oversight of the company.

What does ARCL Organics do?

ARCL Organics Ltd is a micro-cap company in the commodity chemicals industry, incorporated in 1992, with recent quarterly net sales of 722 Cr and net profit of 56 Cr as of March 2025. Key metrics include a P/E ratio of 17.00 and a market cap of INR 203 Cr.

Overview: <BR>ARCL Organics Ltd operates in the commodity chemicals industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The company was incorporated in 1992 and was initially known as Allied Chemical Private Limited. It changed its name to ARCL Organics Private Limited on January 11, 2010, and subsequently became a Public Limited Company on February 08, 2010. The most recent quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 722 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 56 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 203 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 17.00 <BR>Industry P/E: 24 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.21 <BR>Return on Equity: 15.93% <BR>Price to Book: 2.68 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the top shareholders of the ARCL Organics?

The top shareholders of ARCL Organics are Arc Holdings Ltd with 15.29%, followed by Arcl Organics Ltd (SBICAP Trustee) at 11.28%, and individual investors holding 12.36%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of ARCL Organics include Arc Holdings Ltd, which holds the highest promoter stake at 15.29%. Additionally, the highest public shareholder is Arcl Organics Ltd, operated by SBICAP Trustee, with a holding of 11.28%. Individual investors collectively hold 12.36% of the company's shares. Notably, there are no mutual funds or foreign institutional investors (FIIs) currently holding shares in the company.

How big is ARCL Organics?

As of 24th July, ARCL Organics Ltd has a market capitalization of 221.00 Cr, with recent net sales of 250.59 Cr and a net profit of 12.34 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: ARCL Organics Ltd has a market capitalization of 221.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 250.59 Cr, while the sum of Net Profit for the same period is 12.34 Cr.<BR><BR>Balance Sheet Snapshot: For the reporting period of March 2025, Shareholder's Funds are valued at 77.45 Cr, and Total Assets amount to 168.89 Cr.

Are ARCL Organics latest results good or bad?

ARCL Organics' latest results show year-on-year growth in net sales (21.53%) and profit after tax (29.3%), indicating strong performance. However, quarter-on-quarter figures reveal declines in both net sales (6.78%) and net profit (28.75%), leading to a 'Hold' rating for the stock.

ARCL Organics' latest results present a mixed picture. On one hand, the company reported net sales of Rs 201.54 crore, reflecting a year-on-year growth of 21.53%, which is a positive sign indicating strong sales performance. Additionally, the profit after tax (PAT) of Rs 3.99 crore represents a significant increase of 29.3% compared to the average PAT over the previous four quarters, suggesting improved profitability.<BR><BR>However, when looking at the quarter-on-quarter performance, there are notable declines. Net sales decreased by 6.78% compared to the previous quarter, and the consolidated net profit dropped by 28.75%. This indicates a downward trend in the short term, despite the year-on-year growth figures.<BR><BR>Overall, while ARCL Organics shows positive momentum in sales and profitability on a yearly basis, the recent quarterly performance reflects some challenges. The stock is currently rated as a 'Hold', suggesting a cautious approach to its market performance.

How has been the historical performance of ARCL Organics?

ARCL Organics has experienced significant growth over the past four years, with net sales increasing from 141.26 Cr in Mar'22 to 250.59 Cr in Mar'25, and profit after tax rising to 12.33 Cr. Despite a slight decline in operating profit margin, the company has improved its earnings per share and total assets, indicating strong financial health.

Answer:<BR>The historical performance of ARCL Organics shows a steady growth in net sales and profitability over the past four years, with net sales increasing from 141.26 Cr in Mar'22 to 250.59 Cr in Mar'25. The total operating income has followed a similar upward trend, reaching 250.59 Cr in Mar'25, up from 141.26 Cr in Mar'22. The company's total expenditure has also risen, from 126.02 Cr in Mar'22 to 226.78 Cr in Mar'25, primarily driven by increased raw material costs, which rose from 107.66 Cr to 178.83 Cr during the same period. Operating profit (PBDIT) has improved from 17.63 Cr in Mar'22 to 26.16 Cr in Mar'25, although the operating profit margin has slightly declined from 10.79% to 9.5%. Profit before tax has shown a consistent increase, reaching 16.75 Cr in Mar'25, while profit after tax has also grown to 12.33 Cr from 10.53 Cr in Mar'22. The earnings per share have increased from 13.16 in Mar'22 to 15.41 in Mar'25, reflecting the company's profitability growth. On the balance sheet, total assets have increased from 97.89 Cr in Mar'22 to 168.89 Cr in Mar'25, with total liabilities also rising from 97.89 Cr to 168.89 Cr. The book value per share has improved significantly from 53.18 in Mar'22 to 96.81 in Mar'25. Cash flow from operating activities has shown variability, with a cash flow of 5.00 Cr in Mar'25 compared to 1.00 Cr in Mar'22.<BR><BR>Breakdown:<BR>ARCL Organics has demonstrated significant growth in its financial performance over the past four years. Net sales surged from 141.26 Cr in Mar'22 to 250.59 Cr in Mar'25, while total operating income mirrored this growth, reaching 250.59 Cr. Despite rising total expenditure, which increased to 226.78 Cr in Mar'25, the company managed to enhance its operating profit to 26.16 Cr, although the operating profit margin slightly decreased to 9.5%. Profit before tax rose to 16.75 Cr, and profit after tax reached 12.33 Cr, indicating a solid profitability trend. The earnings per share also improved, reflecting the company's financial health. On the balance sheet, total assets and liabilities both increased to 168.89 Cr, and the book value per share rose significantly, showcasing enhanced shareholder value. Cash flow from operating activities was 5.00 Cr in Mar'25, indicating a positive cash generation despite fluctuations in working capital. Overall, ARCL Organics has shown a robust growth trajectory in both revenue and profitability metrics.

Should I buy, sell or hold ARCL Organics Ltd?

Why is ARCL Organics Ltd falling/rising?

As of 02-Feb, ARCL Organics Ltd's stock price is stable at 236.85 but has seen significant declines of 5.03% in the past week and 37.51% year-to-date. Despite these challenges and lower trading volumes, the company shows strong financial health with high management efficiency and substantial profit growth.

As of 02-Feb, ARCL Organics Ltd's stock price is currently stable at 236.85, showing no change (0.00%). However, the stock has experienced a significant decline over various periods, with a 1-week drop of 5.03%, a 1-month decline of 35.74%, and a year-to-date decrease of 37.51%. This underperformance is notable when compared to the Sensex, which has shown a slight increase of 0.16% over the past week and a decline of only 4.17% year-to-date.<BR><BR>The stock's performance today is described as inline with the sector, but it is trading lower than its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a significant drop in investor participation, with delivery volume on February 1 falling by 70.64% compared to the 5-day average. This decline in trading activity suggests a lack of interest from investors, which can contribute to downward pressure on the stock price.<BR><BR>Despite these negative indicators, there are positive factors that could support a hold recommendation for the stock. The company demonstrates high management efficiency with a return on capital employed (ROCE) of 22.47%, a low debt to EBITDA ratio of 0.71 times, and strong long-term growth metrics, including a net sales growth rate of 32.87% and an operating profit growth of 58.19%. Furthermore, the company reported a substantial increase in net profit of 80.95% in its latest quarterly results, indicating strong financial health.<BR><BR>In summary, while ARCL Organics Ltd's stock price is currently stable, the significant declines over recent periods, lower trading volumes, and underperformance relative to benchmarks suggest that the stock is facing downward pressure, despite some positive financial metrics.

Which are the latest news on ARCL Organics?